NDC 67623-001

Exel Clarifying Line SPF 50

Octinoxate, Octocrylene, Oxybenzone, Tatanium Dioxide

Exel Clarifying Line SPF 50 is a Topical Cream in the Human Otc Drug category. It is labeled and distributed by Biocosmetica Exel Argentina Srl. The primary component is Octinoxate; Octocrylene; Oxybenzone; Titanium Dioxide.

Product ID67623-001_99565c26-973b-405a-91a9-31c440de7767
NDC67623-001
Product TypeHuman Otc Drug
Proprietary NameExel Clarifying Line SPF 50
Generic NameOctinoxate, Octocrylene, Oxybenzone, Tatanium Dioxide
Dosage FormCream
Route of AdministrationTOPICAL
Marketing Start Date2015-05-14
Marketing CategoryOTC MONOGRAPH FINAL / OTC MONOGRAPH FINAL
Application Numberpart352
Labeler NameBiocosmetica Exel Argentina SRL
Substance NameOCTINOXATE; OCTOCRYLENE; OXYBENZONE; TITANIUM DIOXIDE
Active Ingredient Strength8 g/100mL; g/100mL; g/100mL; g/100mL
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 67623-001-02

1 TUBE in 1 PACKAGE (67623-001-02) > 100 mL in 1 TUBE (67623-001-01)
Marketing Start Date2015-05-14
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 67623-001-01 [67623000101]

Exel Clarifying Line SPF 50 CREAM
Marketing CategoryOTC monograph final
Application Numberpart352
Product TypeHUMAN OTC DRUG
Marketing Start Date2015-05-14

NDC 67623-001-02 [67623000102]

Exel Clarifying Line SPF 50 CREAM
Marketing CategoryOTC monograph final
Application Numberpart352
Product TypeHUMAN OTC DRUG
Marketing Start Date2015-05-14

Drug Details

Active Ingredients

IngredientStrength
OCTINOXATE7.5 g/100mL

OpenFDA Data

SPL SET ID:e65a68f6-d1b7-4cbf-a3f8-5cc04036221a
Manufacturer
UNII

NDC Crossover Matching brand name "Exel Clarifying Line SPF 50" or generic name "Octinoxate, Octocrylene, Oxybenzone, Tatanium Dioxide"

NDCBrand NameGeneric Name
53863-125Exel Clarifying LineOctinoxate, Octocrylene, Oxybenzone, Tatanium Dioxide
67623-001Exel Clarifying LineOctinoxate, Octocrylene, Oxybenzone, Tatanium Dioxide

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.